中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Homodimerization of human Mu-opioid receptor overexpressed in Sf9 insect cells

文献类型:期刊论文

作者Chen, LW; Can, G; Zhou, DH; Wei, Q; Xu, XJ; Chen, J; Chi, ZQ
刊名PROTEIN AND PEPTIDE LETTERS
出版日期2002-04
卷号9期号:2页码:145-152
关键词G protein coupled receptors Mu opioid receptors Baculovirus Sf9 insect cells homodimerization
ISSN号0929-8665
DOI10.2174/0929866023408850
文献子类Article
英文摘要In this study, we demonstrate that human mu-opioid receptors do form SDS-resistant homodimers and examine the ability of human mu-opioid receptors to dimerize and the role of agonists in the dimerization. Increasing concentrations and longer exposure of agonists reduce the levels of dimmer with a corresponding increase in the levels of monomer. This effect is achieved with both peptide and alkaloid opioid agonists and it is antagonist reversible. These results suggest that human mu-opioid receptors are present as receptor oligomers and interconversion between dimeric and monomeric forms may be important for biological activity.
WOS关键词BACULOVIRUS SYSTEM ; GABA(B) RECEPTOR ; OPIATE-RECEPTOR ; BINDING-SITE ; INTERNALIZATION ; OHMEFENTANYL ; DIMERIZATION ; AFFINITY ; DIMERS
WOS研究方向Biochemistry & Molecular Biology
语种英语
WOS记录号WOS:000175150300007
出版者BENTHAM SCIENCE PUBL LTD
源URL[http://119.78.100.183/handle/2S10ELR8/274373]  
专题药理学第二研究室
院士及顾问专家
药物安全性评价中心
作者单位Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Chen, LW,Can, G,Zhou, DH,et al. Homodimerization of human Mu-opioid receptor overexpressed in Sf9 insect cells[J]. PROTEIN AND PEPTIDE LETTERS,2002,9(2):145-152.
APA Chen, LW.,Can, G.,Zhou, DH.,Wei, Q.,Xu, XJ.,...&Chi, ZQ.(2002).Homodimerization of human Mu-opioid receptor overexpressed in Sf9 insect cells.PROTEIN AND PEPTIDE LETTERS,9(2),145-152.
MLA Chen, LW,et al."Homodimerization of human Mu-opioid receptor overexpressed in Sf9 insect cells".PROTEIN AND PEPTIDE LETTERS 9.2(2002):145-152.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。